A. M. Thirugnanam/LinkedIn
Sep 18, 2026, 15:01
A. M. Thirugnanam: Antiplatelet Discontinuation and the Risk of Stent Thrombosis
A. M. Thirugnanam, Senior Interventional Cardiologist at Kamineni Hospital, India, shared a post on LinkedIn:
“Premature antiplatelet discontinuation remains one of the most preventable causes of stent thrombosis, and it is very often triggered by well meaning advice from outside cardiology before a minor procedure.
Worth sharing with patients and with colleagues who schedule dental and endoscopic work.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience